Exacerbation of harmaline-induced tremor by imipramine

Pharmacology Biochemistry and Behavior

Volumn 81, Issue 1, 2005, Pages 9-14

  Arshaduddin, Mohammed ^a   Kadasah, Saeed ^a   Al Deeb, Saleh ^a   Al Moutaery, Khalaf ^a   Tariq, Mohammad ^a  

^a The General Directorate of Armed Forces Health Services   (Saudi Arabia)

Author keywords

EMG; Harmaline; Imipramine; P chlorophenylalanine; Serotonin; Tremor

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; FENCLONINE; HARMALINE; IMIPRAMINE; SEROTONIN;

5 HYDROXYINDOLEACETIC ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN STEM; CONTROLLED STUDY; DISEASE EXACERBATION; DOSE RESPONSE; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL; SEROTONIN RELEASE; TREMOR; TURNOVER TIME;

ANIMALS; DRUG SYNERGISM; HARMALINE; IMIPRAMINE; MALE; RATS; RATS, SPRAGUE-DAWLEY; TREMOR;

EID: 19344372254     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.01.014     Document Type: Article

References (44)

1. M.A.F. Abdel Fattah, K. Matsumoto, Y. Murakami, K.A.W. El Hady, M. Fayez, and H. Watanabe Facilitatory and inhibitory effects of harmaline on the tryptophan-5-hydroxytryptamine syndrome and body temperature changes in pargyline pretreated rats Jpn J Pharmacol 72 1996 39 47
2. M.A.F. Abdel Fattah, K. Matsumoto, Y. Murakami, G.H. Abdel Khalik, M. Fayez Mohamed, and H. Watanabe Central serotonin level dependent changes in body temperature following administration of tryptophan to pargyline and harmaline pretreated rats Gen Pharmacol 28 1997 405 409
3. S.L. Agarwal, and D. Bose A study of the role of brain catecholamines in drug induced tremors Br J Pharmacol 30 1967 349
4. M. Arshaduddin, S. Al Kadasah, N. Biary, S. Al Deeb, K. Al Moutaery, and M. Tariq Citalopram, a selective serotonin reuptake inhibitor augments harmaline induced tremor in rats Behav Brain Res 153 2004 15 20
5. R.J. Baldessarini Drugs and the treatment of psychiatric disorders: depression and anxiety disorders J.G. Hardman L.E. Limbard Goodman and Gilman: the pharmacological basis of therapeutic 2001 McGraw Hill New York 447 485
6. L.A. Barragan, N. Delhaye-Bouehaud, and P. Laget Drug induced activation of the inferior olivary nucleus in young rabbits Neuropharmacology 24 1985 645 654
7. A. Biegon, M. Segal, and D. Samuel Sex differences in behavior and thermal responses to pargyline and tryptophan Psychopharmacology (Berl) 61 1979 77 80
8. N. Bucholtz, and W.O. Boggan Monoamine-oxidase inhibition in brain and liver produced by B-carbolines structure-activity relationship and substrate specificity Biochem Pharmacol 26 1977 1991 1996
9. L. Cleeves, and L.J. Findley Propranolol and propranolol-LA in essential tremor: a double blind comparative study J Neurol Neurosurg Psychiatry 51 1988 379 384
10. C. De Montigny, and Y. Lamarre Effects produced by local applications of harmaline in the inferior olive Can J Physiol Pharmacol 53 1975 845 849
11. G. Deuschl, and R.J. Elble The pathophysiology of essential tremor Neurology 54 2000 14 20
12. K. Dredge, T.J. Connor, J.P. Kelly, and B.E. Leonard Differential effect of a single high dose of the tricyclic antidepressant imipramine on interleukin-1beta and tumor necrosis factor alpha secretion following an in vivo lipopolysaccharide challenge in rats Int J Immunopharmacol 21 1999 663 673
13. DUAG (Danish University Antidepressant Group) Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study Psychopharmacology 90 1988 131 138
14. DUAG (Danish University Antidepressant Group) Paroxetine selective reuptake inhibitor showing better tolerances, but weaker antidepressant effect than clomipramine in a controlled multicenter study J Affect Disord 18 1990 289 299
15. T. Egashira, F. Takayama, and Y. Yamanaka The inhibition of monoamine oxidase activity by various antidepressants. Differences found in various mammalian species Jpn J Pharmacol 81 1999 115 121
16. J. Gerardy Effect of moclobemide on rat brain monoamine oxidase A and B: co mparison with harmaline and clorgyline Prog Neuropsychopharmacol Biol Psychiatry 18 1994 793 802
17. C.M. Glazener, and J.H. Evans Tricyclic and related drugs for nocturnal enuresis in children Cochrane Database Syst Rev 3 2000 PCD002117
18. C. Gnerre, M. Kosel, P. Baumann, P.A. Carrupt, and B. Testa Interaction of psychotropic drugs with monoamine oxidase in rat brain J Pharm Pharmacol 53 2001 1125 1130
19. J.E. Hardebo, and C. Owman Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood brain interface Ann Neurol 11 1980 1 31
20. H. Kim, S.O. Sablin, and R.R. Ramsay Inhibition of monoamine oxidase A by beta carboline derivatives Arch Biochem Biophys 337 1997 137 142
21. S.Y. Lin Shiau, and K.S. Hsu Modification of 2,2′-tripyridine- induced tremor in mice by serotonergic agonists and antagonists and benzodiazepines Pharmacol Biochem Behav 48 1994 665 670
22. J. Maj, M. Dziedzicka-Wasylewska, R. Rogoz, and Z. Rogoz Effect of antidepressant drugs administered repeatedly on the dopamine D3 receptors in the rat brain Eur J Pharmacol 351 1998 31 37
23. C.D. Marsden Origins of normal and pathological tremor L.J. Findley R. Capildeo Movement disorders: tremor 1984 Macmillan London 37 84
24. N.A. McLeod, and L.E. White Trazodone in essential tremor JAMA 256 1986 2675 2686
25. H. Mehta, B. Thomas, and K.P. Mohanakumar Effects of P- chlorophenylalanine on striatal acetylcholinesterase activity on biogenic amine levels in nuclei raphe and caudate putamen during physostigmine-induced tremor in rats Neurosci Lett 299 2001 105 108
26. H. Mehta, K.S. Saravanan, and K.P. Mohanakumar Serotonin synthesis inhibition in olivo-cerebellar system attenuates harmaline-induced tremor in Swiss albino mice Behav Brain Res 145 2003 31 36
27. K. Modigh Effects of chlorimipramine and protriptylin on the hyperactivity induced by 5-hydroxytryptophan after peripheral decarboxylase inhibition in mice J Neural Transm 34 1973 101 109
28. K.P. Mohanakumar, N. Mitra, and D.K. Ganguly Tremorogenesis by physostigmine in unrelated to acetylcholinesterase inhibition: evidence for serotonergic involvement Neurosci Lett 120 1990 91 93
29. R. Mongeau, P. Blier, and C. De Montigny The serotonergic and noradrenergic, systems of the hippocampus: their interactions and the effects of antidepressants treatments Brain Res Rev 3 1977 145 195
30. S.O. Ogren, S. Carlsson, and T. Bartfai Seorotonergic potentiation of muscarinic agonist evoked tremor and salivation in rat and mouse Psychopharmacology 86 1985 258 264
31. S.O. Ogren, T. Barfai, B. Hedlund, and V.H. Lindberg GEA 857, a putative blocker of potassium conductance, enhances muscarinic agonist evoked responses: dissociation from an action of 5HT mechanisms Pharmacol Toxicol 71 1992 112 119
32. O.E. Patrick, R. Hirohisa, K. Masahiro, and M. Koreaki Central nervous system bioaminergic responses to mechanical trauma Surg Neurol 35 1991 272 279
33. 2-adrenoceptor blockade and 5-hydroxytryptamine mechanism in inhibition of harmaline induced tremors in rats Eur J Pharm 122 1986 111 115
34. P.J. Perry Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants J Affect Disord 39 1996 1 6
35. D.G. Placantonakis, C. Schwarz, and J.P. Welsh Serotonin suppresses subthreshold and suprathreshold oscillatory activity of rat inferior olivary neurons in vitro J Physiol 1 2000 833 851
36. A.H. Rajput, O. Hornykiechicz, Y. Deng, S. Birdi, H. Miyashita, and R. Macaulay Increased noradrenaline levels in essential tremor Neurology 56 Suppl. 3 2001 A302
37. B. Sjolund, A. Bjorklund, and L. Wilklund The indolaminergic innervation of the inferior olive: relation to harmaline induced tremor Brain Res 131 1977 23 27
38. K. Suemaru, H. Araki, and Y. Gomita Involvement of 5-hydroxytryptamine, receptors in nicotine induced tail tremor in rats Eur J Pharm 408 2000 19 23
39. M.J. Tapiador, I. Perez Lopez-Fraile, and A. Lopez-Lopez Essential tremor: a review of pathogenic mechanisms Rev Neurol 160 1998 1059 1065
40. M. Tariq, M. Arshaduddin, N. Biary, K. Al Moutaery, and S. Al Deeb 2-Deoxy-d-glucose attenuates harmaline induced tremors in rats Brain Res 945 2002 212 218
41. J.P. Welsh, and R. Llinas Some organizing principles for the control of movement based on olivocerebellar physiology C.I. De Zeeuw P. Strata J. Boogd Progress in Brain Research vol. 144 1997 Elsevier Amsterdam 449 461
42. J.P. Welsh, D.G. Placentonakis, S.I. Warsetsky, R.G. Marquez, L. Bernstein, and S.A. Archer The serotonin hypothesis of myoclonus from the perspective of neuronal rhythmicity Adv Neurol 89 2002 307 329
43. H. Wilms, J. Sievers, and G. Deuschl Animal models of tremor Mov Disord 14 1999 611 613
44. M.R. Zarrindast, M. Ghiasvand, H. Homayoun, P. Rostami, B. Shafaghi, and S. Khavandgar Adrenoceptor mechanisms underlying imipramine induced memory deficits in rats J Psychopharmacol 17 2003 83 88